<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C0420C4B-DBDD-43F0-BE83-0A439CE2A03B"><gtr:id>C0420C4B-DBDD-43F0-BE83-0A439CE2A03B</gtr:id><gtr:firstName>Fiona</gtr:firstName><gtr:otherNames>M</gtr:otherNames><gtr:surname>Watt</gtr:surname><gtr:orcidId>0000-0001-9151-5154</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5DBAF3CF-6D92-4454-A246-F7F6A2EB3732"><gtr:id>5DBAF3CF-6D92-4454-A246-F7F6A2EB3732</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Durbin</gtr:surname><gtr:orcidId>0000-0002-9130-1006</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_12026"><gtr:id>B30E75BE-F7CD-4400-9ED0-86E8CDF36097</gtr:id><gtr:title>Wellcome Trust MRC Human Inducible Pluripotent Stem Cell Initiative</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_12026</gtr:grantReference><gtr:abstractText>As it becomes cheaper and faster to sequence the DNA of individuals in the population we are faced with two challenges. One is to discover which aspects of the genetic variation between individuals are compatible with good health and which are linked to increased risk of specific diseases. The other is that it is not always obvious why a particular genetic mutation causes a particular disease; if we knew the answer we would be better placed to devise new ways to treat that disease. A technique that can help us meet these challenges is to make stem cells, known as induced pluripotent stem (iPS) cells, from small samples of the skin or blood of healthy and diseased individuals. By comparing the DNA of iPS cells with the way the cells behave when grown in the laboratory we can understand how variation in our DNA results in variation in cell behaviour and use this information to identify new disease mechanisms. The iPS cells and associated data that we generate will be freely available to researchers and doctors throughout the UK and will foster collaborations that will speed up the translation of research into improved diagnosis and treatment of disease.</gtr:abstractText><gtr:technicalSummary>We will exploit the opportunities of the UK National Health Service to generate a national resource of human iPS cells and associated data. We will generate and bank lines from 700 healthy and 800 disease-associated individuals, optimising techniques for iPS cell production and quality control. Cells will be subjected to extensive analysis of genome, epigenome, gene expression and proteome. For cells from healthy individuals, in-depth analysis of inter-individual variability will provide an open access platform for association studies of cellular function, and for distinguishing pathological from physiological variation. Patient collections will be selected via an open call, focusing initially on well-characterised conditions, where a single genetic lesion underlies a pleiotropic clinical phenotype. To characterise cellular phenotype we will construct high throughput artificial microenvironments. We will evaluate cell death, differentiation, morphology and division and specific signalling pathways. We will collaborate to produce protocols to differentiate iPS cells into disease-relevant cell types. These approaches will provide in vitro readouts of inter-individual variation and disease and a platform for gene correction and engineering specific mutations into different genetic backgrounds. Our proposal will give researchers in the UK and beyond access to iPS cells and technology linked to extensive genetic, cellular and clinical information.</gtr:technicalSummary><gtr:fund><gtr:end>2014-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-11-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>4000000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Interview with Times Higher Education (issue number 2,077) on optimal laboratory size</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C626F800-6948-408B-97DC-FF4165FE3434</gtr:id><gtr:impact>Quoted in article.

Stimulated debated.</gtr:impact><gtr:outcomeId>fUBgU8AJrjA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hay Literary Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5EB064F9-A541-4A49-B491-527B1D5BFE51</gtr:id><gtr:impact>Inaugural Rosalind Franklin lecture on behalf of King's College London at Hay Festival. Topic: stem cell research.

Generated national media interest.</gtr:impact><gtr:outcomeId>ou8zQY6ABTp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Advice for applicants for Wellcome Trust Sir Henry Dale Fellowships http://elifesciences.org/elife-news/webinar-report-Sir-Henry-Dale</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E08EB5AC-E740-4055-9438-6AC00BEBE9C1</gtr:id><gtr:impact>Advice to postdocs on obtaining a career development award.</gtr:impact><gtr:outcomeId>58b1c70c2c7a63.96488670</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://elifesciences.org/elife-news/webinar-report-Sir-Henry-Dale</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>short movie about stem cell research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B0727A64-69BA-4A4A-B5A4-EC477923CDA7</gtr:id><gtr:impact>Made video about stem cell research for KCL website; July 2013

Members of my lab participated.</gtr:impact><gtr:outcomeId>bEoKm15vtCE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pint of Science</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E255DC79-F475-428B-B8C4-637FE28666A7</gtr:id><gtr:impact>May 2013: speaker, ' A Pint of Science' festival (http://www.pintofscience.com). Discussion about stem cell research with members of the public.

Lay interest in research.</gtr:impact><gtr:outcomeId>Fb8X3hbEPEh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.pintofscience.com</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview on Korean radio</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E250BBEC-E64C-462F-8FB6-33AFF94D253D</gtr:id><gtr:impact>Interview on UK stem cell research for South Korean live radio programme 'Primetime with Henry Shinn' (http://www.tbs.seoul.kr/efm/Primetime)

Explained UK stem cell research to an international community.</gtr:impact><gtr:outcomeId>JujgTmacpyN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.tbs.seoul.kr/efm/Primetime</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>radio interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>97CB3E52-4749-4A60-9F9C-D7DEFAE2034F</gtr:id><gtr:impact>Gave interviews for BBC Radio 5 Live and the Today programme on report of stem cell therapy for stroke victims; June 2013

Stimulated public interest in stem cell research.</gtr:impact><gtr:outcomeId>LswRGkf3EF5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stem Cell Research: From Utopian Dream to Reality (2016) https://www.youtube.com/watch?v=JIqULf7xJ90&amp;feature=em-subs_digest</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AEB77690-DB1B-439F-8E1B-AEACFB39E6F0</gtr:id><gtr:impact>Exhibition and video as part of 'Utopia 2016' exhibition at Somerset House.</gtr:impact><gtr:outcomeId>58b1c791228599.58828016</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.youtube.com/watch?v=JIqULf7xJ90&amp;feature=em-subs_digest</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B7E8FE3E-BEF5-4735-8F81-6E368EFD465B</gtr:id><gtr:title>A Novel Automated High-Content Analysis Workflow Capturing Cell Population Dynamics from Induced Pluripotent Stem Cell Live Imaging Data.</gtr:title><gtr:parentPublicationTitle>Journal of biomolecular screening</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d34ac3b884966936039375c3a4935f1"><gtr:id>9d34ac3b884966936039375c3a4935f1</gtr:id><gtr:otherNames>Kerz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1087-0571</gtr:issn><gtr:outcomeId>58b1c9a407eba5.01537777</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5FCEF2F-99AF-4882-9E11-E5F92263F85E</gtr:id><gtr:title>Common genetic variation drives molecular heterogeneity in human iPSCs.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0809a810e26e3fe72d42c71e49bbcec0"><gtr:id>0809a810e26e3fe72d42c71e49bbcec0</gtr:id><gtr:otherNames>Kilpinen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a91cfacee96d3.98801261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05222D11-6D3D-4E57-AC51-5349A8BE2854</gtr:id><gtr:title>Scalable topographies to support proliferation and Oct4 expression by human induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8435a969a9e5f799aeea285557bd08a6"><gtr:id>8435a969a9e5f799aeea285557bd08a6</gtr:id><gtr:otherNames>Reimer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56b65c167977e6.55075265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AD6C307-0A2F-4935-ABDA-20FB95F1B2B1</gtr:id><gtr:title>A high-content platform to characterise human induced pluripotent stem cell lines.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25df3abbb45d58d1f4f1b458a06c1eb7"><gtr:id>25df3abbb45d58d1f4f1b458a06c1eb7</gtr:id><gtr:otherNames>Leha A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn><gtr:outcomeId>56b65c171d4804.66704434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B0CBEB3-D65B-4AD2-B95E-5AB7A96BC6FC</gtr:id><gtr:title>Engineered Microenvironments to Direct Epidermal Stem Cell Behavior at Single-Cell Resolution.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84fc124a3cf89ad88fc61f9bea6e581c"><gtr:id>84fc124a3cf89ad88fc61f9bea6e581c</gtr:id><gtr:otherNames>Watt FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>58b1bdc09f8ff9.35562931</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>852C682F-279D-4E6A-ACE9-8828A9632F6C</gtr:id><gtr:title>What is the point of large-scale collections of human induced pluripotent stem cells?</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/709f1f96d06e92c72c13a75be11a178f"><gtr:id>709f1f96d06e92c72c13a75be11a178f</gtr:id><gtr:otherNames>McKernan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_14323_23_24104747</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_12026</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>